An Study to Evaluate Safety and Efficacy of QL-007 Tablets in Combination With Entecavir or Tenofovir in Patients With Chronic Hepatitis b Who Have Received Nucleoside (Acid) Therapy
Condition: Chronic Hepatitis b Interventions: Drug: TDF tablet; Drug: Entecavir Tablet; Drug: QL-007 Sponsor: Qilu Pharmaceutical Co., Ltd. Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials